Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022

SELL
$1.7 - $2.36 $27,837 - $38,645
-16,375 Reduced 42.89%
21,800 $36,000
Q2 2022

Aug 15, 2022

SELL
$1.8 - $6.45 $283,357 - $1.02 Million
-157,421 Reduced 80.48%
38,175 $69,000
Q1 2022

May 16, 2022

BUY
$4.12 - $10.36 $201,410 - $506,458
48,886 Added 33.32%
195,596 $1.05 Million
Q4 2021

Feb 14, 2022

BUY
$6.31 - $11.96 $473,811 - $898,064
75,089 Added 104.84%
146,710 $1.58 Million
Q3 2021

Nov 15, 2021

BUY
$10.15 - $19.88 $726,953 - $1.42 Million
71,621 New
71,621 $797,000

Others Institutions Holding DNAY

# of Institutions
1
Shares Held
307
Call Options Held
0
Put Options Held
0

About Codex DNA, Inc.


  • Ticker DNAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 29,518,200
  • Market Cap $54.6M
  • Description
  • Codex DNA, Inc., a synthetic biology company, manufactures and sells synthetic biology instruments, reagents, and associated products and related services, primarily to pharmaceutical and academic laboratories worldwide. Its solutions include BioXp system that empowers researchers to go from a digital DNA sequence to endpoint-ready synthetic DNA...
More about DNAY
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.